BioMedReports | TalkMarkets | Page 4
Biotech Investing, Healthcare Stocks
Contributor's Links: BioMedReports
BioMedReports.com was co-founded by M.E. Garza and Mike Havrilla in early 2009. Both were successful traders and investors who had historically made some of their BEST TRADESmore

Articles

Latest Posts
49 to 64 of 77 Posts
Novavax To Launch Clinical Trial Of Ebola Vaccine; Sarepta Announces Update On Eteplirsen
Novavax, Inc. will launch a Phase 1 clinical trial of an Ebola vaccine candidate in December.
Active Stocks: PSivida, Galena Biopharma, Cytokinetics, Epizyme, Alexza Pharmaceuticals
Stocks wavered around the unchanged mark in afternoon trade Monday, as investors paused following the biggest weekly gains for major indexes in more than a year.
PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing Of Public Offering
BioMed Reports takes a look at some of the headlines for companies that made news in the healthcare sector this week...
Active Stocks: IsoRay, IDEXX Laboratories, Shire Plc, IGI Laboratories, Vitae Pharmaceuticals
U.S. stocks were on pace to close out their best week in nearly two years on Friday, helped by earnings from Microsoft and Procter & Gamble and as concerns eased over the possible spread of Ebola.
SBOTF And BVTI Sign KLH Supply Agreement For BiovaxID Immunotherapy
SBOTF and BTVI announced the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin for use in Biovest's BiovaxID® active immunotherapy
Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics
U.S. stocks turned lower in afternoon trading on Wednesday, with major indexes erasing earlier gains as a shooting at the Canadian parliament unnerved investors and Boeing and Biogen sold off following results.
AGIO Reports Phase 1/2 Clinical Trial Of AG-221; PSTI Advances Its Second Major Cell Therapy Product Line
Agios Pharmaceuticals announced the initiation of a Phase 1/2 multicenter study of AG-221 in patients with advanced solid tumors. Pluristem Therapeutics announced it has completed development of its second major product line.
Active Stocks: MELA, SGYP, OMER, NVS, ENTA
U.S. stocks rallied on Tuesday, with the S&P 500 on track for a fourth straight session of gains boosted by strong corporate results, including Apple's.
Active Stocks: ADXS, DXCM, CYTK, VRX, NLNK
U.S. stocks moved mostly higher Monday following a turbulent week.
Active Stocks: TTPH, RPRX, HZNP, THRX, MYGN
U.S. stocks rallied Friday, extending a string of sharp moves, amid upbeat economic news from the U.S. and rising hopes for more stimulus from global central banks.
Active Stocks: Merck, OncoGenex, Ibio, OraSure, AbbVie
AbbVie's Shire deal is dead; stocks perk up on Ebola treatment linkage
Healthcare Review: PETX, PLX, CTIX, SMED, ALNY
U.S. stocks slumped, with the Standard & Poor’s 500 Index falling below its 200-day average, as investors weighed prospects for Federal Reserve interest rate increases and slowing global economic growth.
Healthcare Review: GILD, AZN, ASTM, EXAS, LAKE
Ebola-related issues continue to head north. Alpha Pro Tech is up 29% on strong volume.
RMTI Announces FDA Committee Review Of Triferic; HZNP Presents Results Of ACTIMMUNE(R)
Rockwell Medical, Inc. a fully integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services. Horizon Pharma plc announced the presentation of data from a Phase 2 clinical study of ACTIMMUNE
AMGN Declares A Head-to-Head Phase III; CNAT Reports Acceptance Of Abstract For AASLD Meeting
Amgen (AMGN) has claimed gaining regulatory approval for its biosimilar of Humira, AbbVie's (ABBV) mega blockbuster anti-inflammatory drug.
RNN New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine, And Cisplatin
Targeted cancer therapy is a revolution in drug company research, and Rexahn Pharmaceuticals, Inc. recent recipient of a notice of allowance from the US Patent and Trademark Office for a new delivery platform, might one day join the leagueof bigger players.
49 to 64 of 77 Posts